Catalyst Wire Dossier Catalyst Wire Dossier

Vero Cell-derived Japanese Encephalitis Vaccine

Japanese encephalitis vaccine (Vero cell-derived) · Boryung Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vero Cell-derived Japanese Encephalitis Vaccine, covering 2014-01-30 to 2018-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam [Phase 3]

See pricing